Drugs Made In America Acquisition Corp. (DMAA) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-20 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-05-05 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-05-01 | 8-K | Charter Amendments, Shareholder Vote Results, Other Events, Financial Statements & Exhibits | SEC |
| 2026-04-28 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-04-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-27 | 8-K | Material Agreement, Direct Financial Obligation, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-06 | 8-K | Officer / Director Changes | SEC |
| 2026-03-06 | 8-K | Other Events | SEC |
| 2025-11-18 | 8-K | Officer / Director Changes | SEC |
| 2025-02-25 | 8-K | Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-24 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-04 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-30 | 8-K | Material Agreement, Unregistered Sales, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.